Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Calumet Inc has a consensus price target of $23 based on the ratings of 6 analysts. The high is $33 issued by HC Wainwright & Co. on February 12, 2025. The low is $15 issued by UBS on February 4, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., UBS, and HC Wainwright & Co. on February 12, 2025, February 4, 2025, and January 13, 2025, respectively. With an average price target of $27 between HC Wainwright & Co., UBS, and HC Wainwright & Co., there's an implied 91.49% upside for Calumet Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Calumet (NASDAQ:CLMT) was reported by HC Wainwright & Co. on February 12, 2025. The analyst firm set a price target for $33.00 expecting CLMT to rise to within 12 months (a possible 134.04% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Calumet (NASDAQ:CLMT) was provided by HC Wainwright & Co., and Calumet reiterated their buy rating.
The last upgrade for Calumet Inc happened on August 18, 2022 when Goldman Sachs raised their price target to $23. Goldman Sachs previously had a neutral for Calumet Inc.
The last downgrade for Calumet Inc happened on February 4, 2025 when UBS changed their price target from $20.5 to $15 for Calumet Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calumet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calumet was filed on February 12, 2025 so you should expect the next rating to be made available sometime around February 12, 2026.
While ratings are subjective and will change, the latest Calumet (CLMT) rating was a reiterated with a price target of $33.00 to $33.00. The current price Calumet (CLMT) is trading at is $14.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.